Context Therapeutics Inc.

EDGAR

Market value

$18.26M

91,879,177 shares as of 2026-11-06, at $0.1987 a share (CNTX, IEX close on 2026-11-12) Primary-source evidence

30 filing records in this dataset, filed from 2021-05-27 to 2026-11-10. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-06-24 Pasternak Andy A 45,000 0
  • 2026-06-24 West Linda A 45,000 0
  • 2026-06-24 Smith Karen L. A 45,000 0
  • 2026-06-24 Walker Luke Nathaniel A 45,000 0
  • 2026-06-24 Stacey Jennifer Evans A 45,000 0

5% holders (Schedule 13D and 13G)

  • MPM BioImpact LLC 1.4% SCHEDULE 13G/A 06/30/2026
  • Blue Owl Capital Holdings LP 3.19% SCHEDULE 13G/A 06/30/2026
  • Octagon Capital Advisors LP 3.3% SCHEDULE 13G/A 06/30/2026

Institutional holders (Form 13F)

  • Deep Track Capital, LP 7,419,355 SH
  • Nextech Invest Ltd. 7,419,355 SH
  • Soleus Capital Management, L.P. 7,063,141 SH
  • BlackRock, Inc. 6,139,266 SH
  • Avidity Partners Management LP 4,060,254 SH

Trades by members of Congress

See all insider transactions

Cash and cash equivalents
34.4 million USD Source
Exact value

34400000 USD

Long-term debt including current maturities
Not available
Shares outstanding
91.9 million shares Source
Exact value

91879177 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 91879177 shares · 2025-09-30· Source
  • 91879177 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-43.9 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -36123615 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -23098008 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -8680572 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -14558426 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -7623706 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-34 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -26385380 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -17442425 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -11429374 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -18449111 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -11429374 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -25028563 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -18449111 USD · 2026-01-01 – 2026-06-30 Source

Capital expenditure

55.7 thousand USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Capital expenditure: 33948 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 33948 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 37258 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 55746 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 37258 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 55746 USD · 2026-01-01 – 2026-09-30 Source
  • Capital expenditure: 55746 USD · 2026-01-01 – 2026-06-30 Source

Free cash flow

-34 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -26385380 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -17442425 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -11429374 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -18449111 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -11429374 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -25028563 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -18449111 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 33948 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 33948 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 37258 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 55746 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 37258 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 55746 USD · 2026-01-01 – 2026-09-30 Source
  • Capital expenditure: 55746 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-10.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 7 of 11 periods available· newest 2025-12-31
  • Net income: 7 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 7 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 5 of 11 periods available· newest 2025-12-31
  • Total assets: 7 of 11 periods available· newest 2025-12-31
  • Total liabilities: 7 of 11 periods available· newest 2025-12-31
  • Current assets: 7 of 11 periods available· newest 2025-12-31
  • Current liabilities: 7 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 7 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 9.4 million

    Prior period

    −USD 26.73 million

    –

    Current period

    −USD 36.12 million

    –

    Exact inputs and evidence

    -36123615 − -26725104 = -9398511 USD

    -26725104 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -36123615 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 11.83 million

    Prior period

    −USD 14.56 million

    –

    Current period

    −USD 26.39 million

    –

    Exact inputs and evidence

    -26385380 − -14556434 = -11828946 USD

    -14556434 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -26385380 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +364%

    Prior period

    USD 7,316

    –

    Current period

    USD 33,948

    –

    Exact inputs and evidence

    33948 − 7316 = 26632 USD

    7316 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    33948 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2019 2019-01-01 – 2019-12-31
−USD 6.38 million
Exact value

Exact value: -6384169 USD

2019-01-01 – 2019-12-31: -6384169 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 2.84 million
Exact value

Exact value: -2836098 USD

2019-01-01 – 2019-12-31: -2836098 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2020 2020-01-01 – 2020-12-31
USD 6.64 million
Exact value

Exact value: 6644465 USD

2020-01-01 – 2020-12-31: 6644465 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.03 million
Exact value

Exact value: -1034620 USD

2020-01-01 – 2020-12-31: -1034620 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2021-01-01 – 2021-12-31
−USD 10.46 million
Exact value

Exact value: -10456870 USD

2021-01-01 – 2021-12-31: -10456870 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.8 million
Exact value

Exact value: -8799487 USD

2021-01-01 – 2021-12-31: -8799487 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2021-01-01 – 2021-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.8 million
Calculation and evidence

-8799487 − 0 USD

Exact free cash flow: -8799487 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 14.84 million
Exact value

Exact value: -14835939 USD

2022-01-01 – 2022-12-31: -14835939 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 13.55 million
Exact value

Exact value: -13549234 USD

2022-01-01 – 2022-12-31: -13549234 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 36,836
Exact value

Exact value: 36836 USD

2022-01-01 – 2022-12-31: 36836 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 13.59 million
Calculation and evidence

-13549234 − 36836 USD

Exact free cash flow: -13586070 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 23.96 million
Exact value

Exact value: -23964211 USD

2023-01-01 – 2023-12-31: -23964211 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.05 million
Exact value

Exact value: -21047618 USD

2023-01-01 – 2023-12-31: -21047618 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2023-01-01 – 2023-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.05 million
Calculation and evidence

-21047618 − 0 USD

Exact free cash flow: -21047618 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 26.73 million
Exact value

Exact value: -26725104 USD

2024-01-01 – 2024-12-31: -26725104 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 14.56 million
Exact value

Exact value: -14556434 USD

2024-01-01 – 2024-12-31: -14556434 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 7,316
Exact value

Exact value: 7316 USD

2024-01-01 – 2024-12-31: 7316 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 14.56 million
Calculation and evidence

-14556434 − 7316 USD

Exact free cash flow: -14563750 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 36.12 million
Exact value

Exact value: -36123615 USD

2025-01-01 – 2025-12-31: -36123615 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 26.39 million
Exact value

Exact value: -26385380 USD

2025-01-01 – 2025-12-31: -26385380 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 33,948
Exact value

Exact value: 33948 USD

2025-01-01 – 2025-12-31: 33948 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 26.42 million
Calculation and evidence

-26385380 − 33948 USD

Exact free cash flow: -26419328 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

30 filings · 1,178 latest values · 1,178 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001842952, 1842952, CNTX, edgar:1842952

Also known as CONTEXT THERAPEUTICS INC., Context Therapeutics Inc., Context Therapeutics LLC